DOCS (Doximity) Cyclically Adjusted PS Ratio: (As of Jun. 28, 2026)


DOCS Doximity Inc DOCS
82 GF Score
Price $20.88
GF Value $49.18
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Doximity Cyclically Adjusted PS Ratio?

Doximity does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


Doximity  (NYSE:DOCS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Doximity Cyclically Adjusted PS Ratio Related Terms


Doximity Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Doximity's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doximity Cyclically Adjusted PS Ratio Chart

Doximity Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Doximity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

DOCS vs WAY, TXG, HNGE: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, Doximity's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doximity Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Doximity's Cyclically Adjusted PS Ratio falls into.


DOCS
82GF Score
Doximity Inc DOCS
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doximity Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Doximity does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Is Doximity (DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Doximity stock appears to be undervalued. The current stock price of $20.88 is trading 57.5% below its estimated GF Value™ of $49.18. GuruFocus considers Doximity to be Significantly Undervalued.

Key valuation signals for DOCS:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $49.18 vs. price of $20.88 (57.5% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Doximity Business Description

Other Exchanges D2OC34:Brazil
Address 500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score

Get the complete analysis for DOCS

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.88
Price
$49.18
GF Value